MedPath

Evaluation of Use of Diagnostic AI for Lung Cancer in Practice

Not Applicable
Conditions
Lung Cancer
Interventions
Behavioral: AI-human interaction
Registration Number
NCT03780582
Lead Sponsor
Ensemble Group Holdings, LLC
Brief Summary

This study investigates ways of improving radiologists performance of the classification of CT-scans as cancerous or non-cancerous. Participants interact with an AI to classify CT-scans under three different conditions.

Detailed Description

The three conditions are as follows: "probabilistic classification", where the radiologist diagnoses scans using an AI cancer likelihood score; "classification plus detection", where the radiologist see detecting lung nodules in addition to the AI's probabilistic classification score before making her own examination of the CT-scan; and "classification with delayed detection", where the radiologist identifies regions of interest independently of the AI and then sees the AI's detected ROIs.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  • The participant performs radiology screenings professionally
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Probabilistic ClassificationAI-human interactionRadiologists see a "score" from 1-100 that represents the AI's prediction of whether the CT-scan comes from a patient with cancer or not before beginning their analysis of the scan.
Classification Plus DetectionAI-human interactionRadiologists see a "score" from 1-100 that represents the AI's prediction of whether the CT-scan comes from a patient with cancer or not before beginning their analysis of the scan. They also see ROIs identified by the AI that represent lung nodules.
Classification With Delayed DetectionAI-human interactionRadiologists see a "score" from 1-100 that represents the AI's prediction of whether the CT-scan comes from a patient with cancer or not before beginning their analysis of the scan. After identifying their own ROIs, the radiologist then can see ROIs identified by the AI that represent lung nodules before making final decisions.
Primary Outcome Measures
NameTimeMethod
Classification accuracyup to 4 months after initiation of evaluation of the test set

This compares radiologists' classifications with the ground truth in the tested cases.

Secondary Outcome Measures
NameTimeMethod
detection concordanceup to 4 months after initiation of evaluation of the test set

Evaluation of concordance between radiologists in the tested cases in detection of lung nodules \> 4 mm

Trial Locations

Locations (1)

University of Hong Kong

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath